HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer
暂无分享，去创建一个
J. Lequesne | C. Lévy | O. Abramovici | Alison C Johnson | G. Emile | A. Da Silva | D. Allouache | I. Hrab | A. Morel | C. Ségura | F. Cherifi | M. Villemin | A. Broyelle | C. Blanc‐Fournier | C. Boscher | Coraline Dubot-Poitelon | Pauline Rottier | P. Rottier